Leadership Overview
TriRx Pharmaceutical Services has 4 executives leading key functions including strategy, human resources, finance, and operations.
Driven by a commitment to innovation, TriRx Pharmaceutical Services supports customers' commercialization efforts across global markets with specialized contract development and manufacturing solutions for both sterile and non-sterile products.
Driven by a commitment to innovation, TriRx Pharmaceutical Services supports customers' commercialization efforts across global markets with specialized contract development and manufacturing solutions for both sterile and non-sterile products.
Leadership Roles at TriRx Pharmaceutical Services
Timothy Tyson - Chairman & Chief Executive Officer
Timothy Tyson, the Chairman & Chief Executive Officer at TriRx Pharmaceutical Services, directs the overarching corporate strategy and vision. Tyson guides the company's expansion in contract development and manufacturing for non-sterile and sterile products, including animal health injectables and packaging. Overseeing operations across facilities in Huntsville, Alabama, and Segré, France, Tyson ensures TriRx effectively supports global commercialization efforts for pharmaceutical clients. This leadership role involves driving market penetration and fostering strategic partnerships to enhance the company's service offerings. By focusing on advanced solutions, Timothy Tyson positions TriRx Pharmaceutical Services as a key partner for bringing new products to market, emphasizing efficiency and quality in every aspect of development and manufacturing.
Keith Lyon - Executive Vice President & Chief Financial Officer
Keith Lyon, the Executive Vice President & Chief Financial Officer at TriRx Pharmaceutical Services, directs all financial operations and strategic fiscal planning. Lyon oversees budgeting, forecasting, and financial reporting, ensuring the fiscal health of the organization as it expands its contract development and manufacturing services. Managing financial resources across international facilities in Huntsville, Alabama, and Segré, France, is integral to supporting TriRx's global market reach. Keith Lyon plays a crucial part in securing investment and managing capital to drive innovation in sterile and non-sterile product manufacturing. By optimizing financial performance, Lyon enables TriRx Pharmaceutical Services to provide comprehensive solutions, including development, analytics, and packaging, thereby supporting clients' successful commercialization strategies.
James Scandura - Co-Founder & Director & Executive Vice President & Chief Operating Officer
James Scandura, the Co-Founder & Director & Executive Vice President & Chief Operating Officer at TriRx Pharmaceutical Services, leads operational execution and strategic development. Scandura oversees the integrated capabilities in non-sterile and sterile product manufacturing, including animal health injectables and packaging solutions. Directing operations across facilities in Huntsville, Alabama, and Segré, France, ensures TriRx effectively supports customers' commercialization efforts worldwide. James Scandura focuses on enhancing development and analytics services, streamlining manufacturing processes, and optimizing packaging solutions to meet client demands. This leadership ensures TriRx Pharmaceutical Services maintains its position as a premier contract development and manufacturing organization, driving efficiency and quality to bring pharmaceutical products to market.
Richard Mark - Chief Human Resources Officer
Richard Mark, the Chief Human Resources Officer at TriRx Pharmaceutical Services, manages all aspects of human capital strategy and execution. Mark oversees talent acquisition, development, and retention initiatives critical for supporting TriRx's specialized manufacturing capabilities in sterile and non-sterile products. Ensuring a robust organizational structure across global sites, including Huntsville, Alabama, and Segré, France, is a primary focus. Richard Mark drives programs that foster a culture of compliance and operational excellence, essential for pharmaceutical services. This involves aligning HR policies with the company's mission to support clients' commercialization efforts. By cultivating a skilled workforce, Mark directly contributes to TriRx Pharmaceutical Services' capacity to deliver high-quality development and analytics, manufacturing, and packaging solutions to the pharmaceutical industry.
Explore Leadership Teams in Manufacturing
Moderna is recognized as a pioneer in mRNA medicine, reshaping the way treatments and vaccines are created and delivered. By blending scientific innovation with advanced technology, the company continues to transform how society prevents and addresses disease across infectious conditions, cancer, rare disorders and autoimmune challenges. Guided by a distinctive culture and a global team committed to improving human health, Moderna focuses on developing mRNA-based medicines that can make a meaningful and lasting impact.
Company Leadership
KK
SI
PR
Sarepta Therapeutics, Inc. is a global commercial-stage biopharmaceutical company founded in 1980 and headquartered in Cambridge, Massachusetts. The company is focused on the discovery, development, and commercialization of precision genetic medicines for rare diseases, with particular leadership in Duchenne muscular dystrophy and limb-girdle muscular dystrophies. Sarepta's multi-platform Precision Genetic Medicine Engine spans gene therapy, RNA-targeted therapeutics, and gene editing modalities. The company holds multiple FDA-approved treatments and maintains a broad pipeline of programs across neuromuscular and central nervous system disorders. Sarepta operates globally with locations across North America, Europe, and Asia, and trades on the NASDAQ under the ticker symbol SRPT.
Company Leadership AN
KM
IE
WT
Torrent Pharmaceuticals Ltd is the flagship enterprise of the Torrent Group and stands among the leading pharmaceutical companies in India, with a strong and growing international presence. The company is widely recognized for its leadership across key therapeutic areas, including cardiovascular health, central nervous system disorders, gastro-intestinal care, vitamins, minerals and nutritionals, and cosmo-dermatology, while also maintaining a meaningful footprint in diabetology, pain management, gynaecology, oncology and anti-infective treatments. Built on a foundation of scientific excellence and innovation, Torrent Pharma places research and development at the core of its strategy, supported by advanced infrastructure and a highly skilled scientific workforce dedicated to developing high-quality, affordable medicines for patients worldwide.
Company Leadership SM
HP
VG
AV
Shionogi & Co., Ltd. is a Japanese pharmaceutical company dedicated to developing innovative treatments that improve patient lives worldwide. With a longstanding focus on addressing pressing global health challenges, the company has been a pioneer in discovering and delivering novel therapies for infectious diseases, including antibiotics, HIV, influenza, and emerging viral threats such as COVID-19. Shionogi combines in-house research and development with strategic collaborations across industry, government agencies, biotech companies, and academic institutions to accelerate the advancement of its scientific programs and bring meaningful therapies to patients with urgency and precision.
Company Leadership TK
TN
MF
Frequently Asked Questions Regarding TriRx Pharmaceutical Services Top Executives and Leadership Team
